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Background: Objective quantification of emphysema using computerized tomography (CT)
density measurements is rapidly gaining wide acceptance as an in vivo measurement tool.
However, some studies have suggested that abnormal lung function in the absence of
emphysema can affect lung density, and the role of such measurements in identifying and
monitoring the progression of emphysema is not clear.
Objective: To clarify the relationship between lung density measurements and pulmonary
function.
Methods: CT measurements of the proportion of lung occupied by low density tissue (as
percentage of lung area below predetermined Hounsfield unit [HU] thresholds) were obtained
in a large random population (n=739) and the association with detailed pulmonary function
tests studied using factor analysis.
Results: Density measurements showed a greater association with measures of hyperinflation
and airflow obstruction than measures of gas transfer (correlation coefficient, high resolution
scan, –950HU threshold vs FEV1/FVC, RV, and DLCO/VA of –0.39, 0.22, and –0.15
respectively). The strongest lung density factor coefficients of 0.51 (standard resolution scan,
–950HU threshold) and 0.46 (high resolution scan, –910HU threshold) were seen with factors
predominantly consisting of measures of airflow obstruction and hyperinflation. Most variation
in lung density was not accounted for by lung function measurements (communality 0.21–
0.34).
Conclusion: Lung density measurements associate most strongly with measures of airway
disease that are not specific to emphysema.
Keywords: emphysema, CT lung density, COPD, lung function tests
Introduction
The application of computerized tomography (CT) scanning in the detection and
assessment of emphysema has evolved since the 1980s when it was first demonstrated
that objective CT measurements could be used to detect the presence of emphysema
(Hayhurst et al 1984). Through the use of a density threshold, an objective method of
CT quantification was developed whereby the proportion of lung with attenuation
below a predetermined value, expressed relative to the total area of that particular
lung slice, was calculated (Muller et al 1988). Several thresholds have been proposed
to quantify the extent of emphysema (Cosio et al 2001), with the relative area of lung
with attenuation values below –910 and –950 Hounsfield units (HU) being shown to
correlate closely with macro- and microscopic pathological features of emphysema
(Muller et al 1988; Genenois et al 1995; Gevenois, De Vuyst, de Maertelaer, et al
1996). Lung density measurements have also been shown to correlate with
measurements of the degree of abnormal lung function in emphysema, including
FEV1 and diffusing capacity (Kinsella et al 1990; Gould et al 1991). However, other
authors have reported an increase in areas of low attenuation in asthma (Newman et
Suzanne Marsh1
Sarah Aldington1
Mathew V Williams1
Michael Nowitz2
Andrew Kingzett-Taylor2
Mark Weatherall3
Phillipa Shirtcliffe1
Alison Pritchard1
Richard Beasley1,4
1Medical Research Institute of New
Zealand, Wellington, New Zealand;
2Pacific Radiology Limited,
Wellington, New Zealand;
3Wellington School of Medicine &
Health Sciences, Wellington, New
Zealand; 4University of Southampton,
United KingdomInternational journal of COPD 2006:1(2)
Marsh et al
182
al 1994; Biernacki et al 1997; Mitsunobu et al 2001),
suggesting that this feature may not be specific to
emphysema.
In this study we set out to clarify the relationship of RA%
lung density measurements (the relative area of lung tissue
below the threshold density expressed as a percentage of
the total area of that lung slice) to detailed pulmonary
function tests using a large population sample. By exploring
these associations at different thresholds, using different CT
reconstruction algorithms we aimed to investigate the likely
influence of changes in lung function on density
measurements and therefore explore the relationship
between these measurements and the presence of obstructive
airways disease.
Methods
Study participants
Study participants were recruited from a postal screening
survey sent to 3500 people aged 25–75 years, randomly
selected from the electoral register. Subjects completing the
screening survey were invited to attend the research centre
to complete an interviewer-administered, written
questionnaire followed by visits to undertake detailed
respiratory function testing and a CT scan of the chest.
Written questionnaire
All participants completed a detailed written questionnaire
compiled from a series of validated questionnaires (Pistelli
et al 2001) administered by a trained interviewer in a
standardized manner. The Wellington Ethics Committee
approved the study and written informed consent was
obtained from each subject.
Pulmonary function testing
Pulmonary function tests were carried out on 1 site by 1 of
3 trained operators (SA, SM, MVW), using two Jaegar
Master Screen Body volume constant plethysmography units
with pneumotachograph and diffusion unit for spirometry
and measurement of gas transfer (Masterlab 4.5 and 4.6
Erich-Jaegar, Wurzburg, Germany). Equipment was
calibrated daily prior to testing.
Subjects were requested to avoid carbonated drinks and
caffeine for 6 hours and refrain from smoking for 2 hours
prior to testing. Subjects that had been prescribed inhaled
medication were instructed not to use short-acting
bronchodilators for 6 hours and to avoid long-acting
bronchodilators (long-acting beta agonists or anticholinergic
agents) for 36 hours prior to testing. Inhaled corticosteroids
or other medication was not altered. Testing did not occur
within 3 weeks of an upper or lower respiratory tract
infection (new or increased cough, sputum production, sore
throat or nasal congestion). Subjects over 125kg in weight
were excluded due to the weight restriction of the CT
scanner.
All pulmonary function tests were carried out in
accordance with American Thoracic Society (ATS) and
European Respiratory Society (ERS) criteria (ATS 1995a;
1995b; Coates et al 1997) and a nose clip was worn for all
tests. Airway resistance was measured during relaxed
breathing at a rate of approximately 0.5Hz. Following a
minimum of 10 measurements of airway resistance (Rtot)
and attainment of a stable baseline representing functional
residual capacity (FRC), the plethysmography shutter was
closed, occluding breathing for 2–3 seconds. During this
time the subject was instructed to pant gently, without glottis
closure, and thoracic gas volume at FRC was calculated.
Immediately following FRC measurement the subject was
instructed to breath out comfortably, maximally inspire and
slowly expire to completely empty for measurement of slow
vital capacity (SVC). Expiratory reserve capacity (ERV) was
measured from FRC to the point of maximum expiration
and residual volume (RV) was calculated from FRC–ERV.
The total lung capacity (TLC) was calculated as SVC
(measured)+RV. Specific conductance (sGaw) and
resistance (sRaw) were calculated from measurements of
airway resistance and FRC. A minimum of 3 and usually 5
measurements of FRC were carried out and maximum values
from individual maneuvers for ERV and SVC were used in
the above calculations.
Following measurement of static lung volumes a
minimum of 3 acceptable spirometry maneuvers were
carried out with the best FEV1 and FVC selected for analysis.
Maximal mid expiratory flow rate (FEF25-75) was taken from
the maneuver with the best combination of FEV1 and FVC.
For gas transfer measurement, washout and sample volumes
of 750ml were used except in subjects with COPD or asthma
who were unable to manage this when a decrease was made
to a minimum of 500ml. Gas transfer measurements were
expressed as raw values (DLCO) and corrected for alveolar
volume (DLCO/VA). All results were corrected for body
temperature, atmospheric pressure, and water saturation
(BTPS) and expressed as a percentage of predicted based
on the formulae of the ERS (Cotes et al 1993; Quanjer et al
1993) except for FEV1/FVC which was expressed as anInternational Journal of COPD 2006:1(2) 183
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absolute ratio, and sGaw which was expressed as a
percentage of the lower limit of normal (Quanjer et al 1983).
CT scanning
Subjects were scanned using a single machine (GE Prospeed,
General Electric Medical Systems, YMS, Japan) by
radiographers specifically trained in the study protocol. The
scanner was calibrated at weekly intervals using the
manufacturers’ standard phantom. Scans were obtained at
full inspiration with a breath hold time of 4.5 seconds and
no intravenous contrast was used. Three images were
obtained at levels of 1cm above the aortic arch, 1cm below
the carina, and 3cm above the top of the right hemi-
diaphragm (Mishima et al 1999) with a 1mm collimation
and a voltage of 120kVp. Images were reconstructed using
high (GE bone) and low spatial frequency (GE standard)
algorithms and the manufacturer’s “density mask” program
was used to measure tissue density. The trachea and main
stem bronchi were excluded from measurements of lung area
and the total area of lung tissue per slice was calculated
using a density of –300 to –1200HU to separate lung tissue
from the chest wall. The areas of tissue below the thresholds
of –950HU and –910HU were expressed as a percentage
of the total lung area for that slice as the RA950 and RA910
respectively (Gevenois et al 1995).
Statistical analysis
Simple descriptive statistics were used to describe the subject
characteristics and lung density estimates both for individual
slices and the average of the 3 slices for each measurement
technique. Product moment correlation coefficients were
calculated for lung function and lung density measurements.
Factor analysis by an initial principal components method
followed by a varimax rotation with Kaiser normalization
was used to determine which measures of lung function were
associated with lung density measurements. The measures
of lung function entered into the factor analysis were: FEV1
percent predicted, FEV1/FVC ratio, FEF25-75 percent
predicted, and sGaw percent of lower limit of normal
(measures of airflow obstruction); RV and TLC percent
predicted (measures of hyperinflation); DLCO and DLCO/
VA percent predicted (measures of gas transfer). This method
of analysis finds coefficients for each variable that associates
them with a particular underlying factor. In this case 3
underlying factors were expected to be present: airflow
obstruction, lung hyperinflation, and gas transfer. The
coefficients vary from –1 to 1 and if variables have high
absolute values of coefficients then they load highly, are
highly correlated, on to a particular factor. Communality,
or the proportion of variation in the original variables that
is explained by the new factors, was calculated for the factor
analysis. A proportion close to 1 means that most of the
variation in the original variables is explained by the
underlying factors while a communality close to zero means
little variation in the original variable is explained by the
underlying factors. SAS version 8.2 was used for all
analyses.
Results
The initial recruitment resulted in 2319 responses from 3500
screening questionnaires. With the exclusion of the 508
subjects unable to be traced from the address on the electoral
register and 13 subjects who had died, this represented a
response rate of 2319/2979 (78%). Of those subjects who
completed the screening questionnaire, 758 completed the
detailed questionnaire and undertook pulmonary function
tests. 739 of these (97%) had CT scans. Of these, 549 had
scans that were reconstructed using both algorithms and
assessed at both thresholds. 175 subjects had scans that were
reconstructed with a high resolution algorithm and assessed
for RA950 only, and the remaining 15 had images with a
high reconstruction algorithm assessed for both thresholds.
Most subjects were able to complete all 3 modalities of
pulmonary function testing (airway resistance and static lung
volumes, dynamic lung volumes, and gas transfer
measurements); however 19 subjects were unable to
satisfactorily complete plethysmography measurements and
7 subjects were not able to complete flow volume loops.
Gas transfer measurements were completed by all but 26
subjects.
Table 1 shows the epidemiological characteristics and
results of pulmonary function tests of the subjects. There
was a slight excess of male subjects (n=405, 54.8%), 74
subjects (10%) were current smokers, 295 were past smokers
(40%) (pack years, all smokers, mean [SD], 15 [18.0] range
0.03–171).
The lung density measurements for the individual slices
and the mean of all 3 slices are shown in Table 2. The apical
RA% values were smaller than those at the other 2
standardized sites. Higher RA% values were observed with
the high (compared with standard) resolution algorithm and
with the –910HU (compared with the –950HU) threshold.
As the correlation between RA% values for individual slices
was strong (data not shown) further analyses were carried
out using data presented as the mean of all 3 slices.International journal of COPD 2006:1(2)
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The correlation matrix for lung function tests and lung
density for the high resolution algorithm and threshold of
–950HU (Table 3) shows that RA950 was poorly correlated
with most lung function variables, with the highest
correlation coefficient of –0.39 seen with FEV1/FVC.
Similar results (not shown) were seen with the other
reconstruction algorithms and thresholds.
The results for the factor analysis are shown in Tables 4
and 5. In high resolution scans (Table 4a and b) lung density
measurements predominantly clustered on to measurements
associated with hyperinflation (RV and TLC). The strongest
Table 1 Subject characteristics including pulmonary function
tests
Characteristic of population (n=739) Mean (SD) Range
Age (years) 53.6 (12.8) 26–75
FEV1/FVC % predicted 74.2 (8.9) 31–95
FEV1 % predicted 106.5 (21) 24–161
FEF25-75 % predicted 74.2 (28.9) 6–181
sGaw % lower limit of normal 132.9 (48.6) 15–345
RV % predicted 107 (25.9) 39–303
TLC% predicted 110.3 (12.6) 61–155
DLCO % predicted 94.3 (14.8) 28–138
DLCO/VA % predicted 96.5 (14.4) 42–145
Smokers (current n=74, past n=295)
Cigarette pack years (all smokers) 15 (18.0) 0.03–171
Abbreviations:
 DLCO, transfer factor for carbon monoxide; FEF25-75, maximum
forced expiratory flow rate; FEV1, forced expiratory volume in 1 second; FVC,
forced vital capacity; sGaw, airway conductance; RV, residual volume; TLC, total
lung capacity; VA, alveolar volume.
Table 2  Descriptive statistics for lung density measurements
Reconstruction algorithm and Level
b Number of Mean (SD)
a Median (inter- Range
a
threshold subjects quartile range)
a
High resolution –950 HU Level 1 739 13.1 (8.0) 11.9 (7.3–17.5) 0.02–68.3
Level 2 739 15.4 (7.3) 15.2 (10.1–20.7) 0.39–57.3
Level 3 739 15.5 (7.4) 15.0 (9.9–20.5) 0.07–38.5
Mean 739 14.7 (7.1) 14.4 (9.2–19.9) 0.52–50.7
High resolution –910 HU Level 1 549 31.3 (12.4) 31.2 (22.0–39.3) 2.4–79.4
Level 2 548c 35.8 (12.2) 37.0 (27.4–45.0) 3.0–70.2
Level 3 549 34.6 (12.3) 35.6 (25.5–43.9) 0.43–60.2
Mean 549 33.9 (11.8) 34.8 (25.3–43.2) 4.0–68.2
Standard resolution –950HU Level 1 564 1.28 (5.1) 0.14 (0.03–0.65) 0–68.2
Level 2 564 2.33 (3.5) 1.4 (0.58–2.78) 0–54.4
Level 3 564 3.63 (3.7) 2.5 (1.2–4.70) 0–31.5
Mean 564 2.41 (3.5) 1.4 (0.67–2.80) 0–45.9
Standard resolution –910HU Level 1 549 16.4 (16.7) 10.4 (2.8–25.1) 0–81.3
Level 2 549 24.6 (16.8) 22.7 (10.1–37.5) 0.1–72.7
Level 3 549 24.5 (15.7) 23.2 (10.8–36.0) 0.01–63.5
Mean 549 21.8 (15.5) 19.4 (8.2–33.9) 0.15–64.2
aResults are presented as RA% values, the proportion of lung tissue below the threshold density expressed relative to the total area of that lung slice.
bLevel 1: 1 cm above the aortic arch, Level 2: 1 cm below the carina, and Level 3: 3 cm above the top of the right hemi-diaphragm.
cDue to a technical problem it was not possible to analyse data for 1 subject.
association for lung density measurements, obtained with
the standard resolution algorithm and –950HU threshold
(Table 5a), was with measurements of airflow obstruction
with a component of hyperinflation (RV). Standard
resolution scans with –910HU threshold (Table 5b) showed
a weaker and more inconsistent result, with slightly greater
loading on to factors with predominant components of
hyperinflation and airflow obstruction. Weak clustering with
gas transfer variables was seen only for the standard
resolution scans and –950HU threshold (Table 5b).
Communality of the lung density measurements for each
of the 4 combinations of algorithm and threshold values is
low (0.21–0.34) (Tables 4 and 5). This means that most
variation in lung density is not accounted for by the lung
function tests included in the factors (1, 2, and 3) identified
in the factor analysis. In contrast the communality for
individual lung function measurements, except for sGaw, is
high (0.72–0.97) (Tables 4 and 5), meaning variation within
individual lung function measurements (except sGaw) is
largely explained by the underlying factors (1, 2, and 3)
identified. As a result, sGaw is likely to be measuring a
component of airway physiology not accounted for by the
other parameters.
Discussion
This study has shown that measurements of lung density
have, as their most dominant relationship, a consistentInternational Journal of COPD 2006:1(2) 185
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Table 3  Correlation matrix for lung function tests and lung density for high resolution scan and – 950 HU threshold
HR950 mean
a DLCO DLCO/VA FEV1 FEV1/FVC MMEF RV sGaw TLC
HR950 mean
a 1.00 –0.10 –0.15 –0.13 –0.39 –0.19 0.22 –0.03 0.17
DLCO –0.10 1.00 0.71 0.42 0.22 0.29 –0.19 0.22 0.18
DLCO/VA –0.15 0.71 1.00 –0.01 0.67 0.15 –0.37 0.23 –0.47
FEV1 –0.13 0.42 –0.01 1.00 0.21 0.76 –0.42 0.44 0.36
FEV1/FVC –0.39 0.22 0.21 0.67 1.00 0.85 –0.56 0.45 –0.22
MMEF –0.19 0.29 0.15 0.76 0.85 1.00 –0.45 0.51 0.01
RV 0.22 –0.19 –0.37 –0.42 –0.56 –0.45 1.00 –0.46 0.57
sGaw –0.03 0.22 0.23 0.44 0.45 0.51 –0.46 1.00 –0.18
TLC 0.17 0.18 –0.47 0.36 –0.22 0.01 0.57 –0.18 1.00
aLung density measurements for high resolution scan, – 950 HU threshold as a mean of all 3 slices
See Table 1 for abbreviations.
Table 4  Factor analysis for mean lung density measurements for high resolution CT scans for a) – 950 HU threshold and
b) – 950 HU threshold
Table  4a
Original variable Factor 1 loading
a Factor 2 loading Factor 3 loading Communality
b
HR950 mean
c –0.25 0.39 – 0.02 0.21
DLCO 0.28 0.17 0.93 0.97
DLCO/VA – 0.01 –0.42 0.87 0.96
FEV1 0.91 0.25 0.14 0.91
FEV1/FVC 0.84 –0.34 0.06 0.83
MMEF 0.92 –0.09 0.09 0.86
RV –0.48 0.69 – 0.15 0.73
sGaw 0.58 0.27 0.15 0.43
TLC 0.18 0.95 – 0.06 0.94
Table 4b
Original variable Factor 1 loading Factor 2 loading Factor 3 loading Communality
HR910 meand –0.12 0.46 0.01 0.22
DLCO 0.27 0.19 0.93 0.97
DLCO/VA 0.03 –0.39 0.90 0.97
FEV1 0.90 0.29 0.13 0.90
FEV1/FVC 0.85 –0.31 0.08 0.83
MMEF 0.92 –0.06 0.10 0.86
RV –0.52 0.64 –0.17 0.72
sGaw 0.60 –0.24 0.13 0.43
TLC 0.13 0.95 –0.09 0.93
aFactor analysis finds coefficients (–1 to 1) for each variable associating them with a particular underlying factor (in this case factors 1 to 3). If variables have high
absolute coefficient values then they are highly correlated onto a particular factor.
bCommunality expresses the proportion of variation in the original variables explained by the new factors. A proportion close to 1 means most of the variation in the
original variables is explained by the underlying factors.
cLung density measurements for high resolution scan, – 950 HU threshold, as a mean of all 3 slices.
dLung density measurements for high resolution scan, – 950 HU threshold, as a mean of all 3 slices.
See Table 1 for abbreviations.
association with hyperinflation in all 4 reconstruction
algorithm and threshold models. Weaker associations are
seen with airflow obstruction and essentially no association
is seen with gas transfer variables.
Methodological issues
We chose a limited 3-scan CT protocol based on a need to
reduce radiation exposure in a research setting and evidence
that a 3-slice protocol gives information closely comparable
with that of more detailed 10-slice assessments (Mishima
et al 1999). Although it has been suggested that expiratory
scans are more closely correlated with physiological
variables consistent with a diagnosis of emphysema
(Knudson et al 1991), Gevenois, De Vuyst, Sy, et al (1996)
found inspiratory scans to be superior when compared with
pathological measurements. Scans taken as close to TLC asInternational journal of COPD 2006:1(2)
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Table 5  Factor analysis for mean lung density measurements for standard resolution CT scans for a) – 950 HU threshold and
b) – 950 HU threshold
Table 5a
Original variable Factor 1 loading Factor 2 loading Factor 3 loading Communality
STD950 mean
a 0.51 0.23 –0.16 0.34
DLCO 0.55 0.00 0.80 0.95
DLCO/VA 0.53 –0.58 0.55 0.92
FEV1 0.71 0.63 0.03 0.91
FEV1/FVC 0.86 0.13 –0.24 0.82
MMEF 0.83 0.37 –0.17 0.85
RV 0.72 0.34 0.31 0.74
sGaw 0.62 0.03 –0.26 0.46
TLC – 0.24 0.88 0.37 0.96
Table 5b
Original variable Factor 1 loading Factor 2 loading Factor 3 loading Communality
STD910 mean
a – 0.28 0.32 0.21 0.23
DLCO 0.54 0.06 0.82 0.97
DLCO/VA 0.51 –0.54 0.64 0.97
FEV1 0.73 0.61 –0.01 0.91
FEV1/FVC 0.87 0.09 –0.27 0.83
MMEF 0.85 0.33 –0.17 0.80
RV – 0.72 0.37 0.24 0.72
sGaw 0.64 0.03 –0.13 0.42
TLC 0.24 0.90 0.26 0.93
aLung density measurements for standard resolution scan, – 950 HU threshold, as a mean of all 3 slices.
See Table 1 and Table 4 for abbreviations and explanation of terms.
possible are recommended for longitudinal follow up of
emphysema (Newell et al 2004). Two density thresholds
(– 910 and – 950HU) were used based on previous
correlations with pathological measures and pulmonary
function tests (Muller et al 1988; Kinsella et al 1990;
Gevenois et al 1995; Gevenois, De Vuyst, Maertelaer, et al
1996). A 1mm collimation was used as this has been
employed in studies showing a close macro- and microscopic
association between lung density measurements and
emphysema (Gevenois et al 1995; Gevenois, De Vuyst,
Maertelaer, et al 1996).
Relationship between physiological
measurements and lung density
The finding that lung density measurements associate most
closely with measures of airflow obstruction and
hyperinflation are consistent with those of Mitsunobu et al
(2001) who, in subjects with asthma, found a strong
correlation between RA950 levels and FEV1, FEV1/FVC,
and RV but no correlation with measures of gas transfer.
Similarly Kinsella et al (1990) found that a “density mask”
threshold of –910HU correlated most strongly with FEV1/
FVC and more weakly with measures of gas transfer.
Conversely Gould et al (1991), using the lowest 5th
percentile derived from CT density histograms, found the
correlation with gas transfer to be greater than that with
FEV1/FVC and showed weaker, but significant relationships
with measurements of lung volume (RV and TLC). Different
correlations between density measurements and pulmonary
function parameters between studies may be due, in part, to
the size and nature of the population groups being studied.
Two of the previous studies (Kinsella et al 1990; Gould et
al 1991) had relatively small samples of around 80 subjects
and included few “normal” subjects in respect of respiratory
health and smoking status. By using factor analysis and a
large number of randomly selected subjects to explore the
relationship of lung density measurements to pulmonary
function tests in a diverse population, this problem is
overcome and we were able to address the question of which
lung function parameters are reflected by lung density.
Prior to CT scanning, pulmonary function tests have
represented the best noninvasive method to indicate theInternational Journal of COPD 2006:1(2) 187
Physiological associations of CT lung density
presence of emphysema. Although not a gold standard
compared with anatomical diagnosis, assessment of gas
transfer, through the measurement of diffusing capacity, is
often considered to be one of the best predictors of
emphysema (Heremans et al 1992) and is the best single
physiological discriminator between subjects with asthma
and COPD (Sciurba 2004). In addition gas transfer
measurements correlate more closely with microscopic
pathological measurements of emphysematous change than
do measures of airflow obstruction and hyperinflation
(Gould et al 1988; Gevenois, De Vuyst, Maertelaer, et al
1996). By showing that RA% values cluster most strongly
with physiological measurements that are not specific to
emphysema the validity of a measurement of RA% as an
index of emphysema is called into doubt.
Our findings suggest that the use of lung density
measurements in the longitudinal assessment of emphysema
may be confounded by short-term variations in airflow
obstruction and hyperinflation. Such variations could cause
significant changes in lung density unrelated to the
progression of emphysema.
Conclusion
We conclude that lung density measurements correlate more
strongly with measures of hyperinflation and airflow
obstruction than with measures of gas transfer. Such
measurements should be used with caution in the long-term
assessment of the progression of emphysema. The ability
of lung density measurements to diagnose emphysema and
discriminate it from other forms of obstructive airway
disease awaits further study.
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